Triglyceride glucose-body mass index is associated with cardiovascular outcomes and overall mortality in type-2 diabetes mellitus patients

Table 3 Analysis of the threshold effects of triglyceride glucose-body mass index levels on cardiovascular and total mortality

Outcomes	One linear-regression model	Inflection point (K)	< K, effect 1	> K, effect 2	P value for LRT
Cardiovascular mortality	1.03 (1.02, 1.05), P < 0.0001	252.77	0.95 (0.89, 1.01), P = 0.1161	1.05 (1.03, 1.06), P < 0.0001	0.012
Total mortality	1.02 (1.01, 1.03), P < 0.0001	245.90	0.96 (0.92, 1.00), P = 0.0302	1.03 (1.02, 1.04), P < 0.0001	0.002

The effects shown are adjusted for model 3, including sex, race, age, education, history of cardiovascular disease, previous hypertension, previous hyperlipidemia, systolic blood pressure, diastolic blood pressure, duration of diabetes, proteinuria, heart failure, smoking status, glycated hemoglobin, total cholesterol, low density lipoprotein-cholesterol, estimated glomerular filtration rate, calcium channel blocker, beta-blockers, biguanides, thiazolidinediones, insulin, aspirin, cholesterol absorption inhibitors. LRT: Likelihood ratio test.